TB-4 vs TB-500: why true Thymosin Beta-4 is not interchangeable
TB-4 and “TB-500” are often discussed as if they are the same thing. They are not. From a molecular, documentation, and traceability standpoint, the difference matters — especially for serious research workflows. Research use only.
Why TB-4 and TB-500 are constantly confused
“TB-500” is not a formally defined peptide. It is a market shorthand that has evolved to describe fragments, analogs, or interpretations inspired by Thymosin Beta-4 — often without explicit disclosure of composition.
Over time, repetition has created the false impression that TB-500 and TB-4 are interchangeable. From a documentation perspective, this introduces ambiguity, weakens batch records, and makes internal comparisons unreliable.
“TB-500” is a label that may refer to different things depending on the supplier.
What true TB-4 actually is
Thymosin Beta-4 is a specific peptide with a known amino acid sequence. This allows it to be referenced consistently across documentation, batches, and internal records.
- Explicit molecular definition
- Consistent naming across batches
- Clear reference point for verification
Aventris supplies true TB-4 with verification-first documentation and batch-specific identifiers.
What “TB-500” usually represents
TB-500 commonly refers to shorter fragments or derivatives inspired by TB-4. The exact structure is often unspecified and can vary between sources.
- No single defined sequence
- Supplier-dependent interpretation
- Reduced traceability
Why this matters for serious records
When identity is vague, COAs become harder to interpret and batch records lose precision. Aventris avoids umbrella terms so internal documentation stays clean and auditable.
- Clear identifiers
- Batch-linked verification pages
- Reduced ambiguity over time
Why cheaper substitutions dominate the market
Many products labeled “TB-500” exist because fragments are cheaper and easier to produce. Lower cost often comes at the expense of clarity, consistency, and documentation quality.
- Simplified production
- Inconsistent composition
- Difficult to compare across batches
Why Aventris supplies true TB-4
Aventris does not treat TB-4 and TB-500 as interchangeable. We focus on explicit molecular identity, batch-specific documentation, and verification pages designed for internal use.
When you reference TB-4 from Aventris, you are referencing the same defined material every time — supported by consistent identifiers and documentation standards.
- True TB-4 (not shorthand)
- Batch-linked verification pages
- Documentation built for records, not marketing
View Thymosin Beta-4 (TB-4) →
Bottom line
TB-4 and TB-500 are often conflated — but they are not equivalent. One is a defined peptide with a stable identity. The other is a flexible label that can mean different things depending on the source.
For research environments that value documentation clarity and repeatability, that distinction matters.